Table 5.

Percentages of CD4/CD8 thymocyte subsets and TCRγδ cells in 15·5-day fetal (E15·5), 17.5-day fetal (E17·5) and neonatal (2PN) WT and EphB-deficient mice

	DN	DP	CD4	CD8	TCRγδ
(a) E15·5
Wild type	95·08 ± 1·08	0·24 ± 0·18	0·61 ± 0·35	3·10 ± 1·09	2·09 ± 0·80
EphB2−/−	98·27 ± 1·80***	0·07 ± 0·04***	0·40 ± 0·13*	0·91 ± 0·39***	1·09 ± 0·77***
EphB3−/−	98·63 ± 0·79***	0·03 ± 0·03***	0·61 ± 0·29	0·54 ± 0·41***	1·22 ± 0·83**
EphB2/B3−/−	98·95 ± 1·06***	0·04 ± 0·02***	0·19 ± 0·13***	0·18 ± 0·03***	0·97 ± 0·52***
(b) E17·5
Wild type	32·89 ± 4·01	54·84 ± 3·26	7·49 ± 2·72	3·85 ± 1·21	1·91 ± 0·46
EphB2−/−	43·42 ± 2·91***	49·62 ± 3·36*	1·81 ± 0·68***	4·33 ± 0·92	3·00 ± 1·16**
EphB3−/−	41·85 ± 3·91**	48·75 ± 1·19**	4·12 ± 0·25***	4·92 ± 1·56	2·59 ± 0·54*
EphB2/B3−/−	42·84 ± 2·35***	50·32 ± 2·44*	2·26 ± 0·38***	4·26 ± 0·64	2·32 ± 0·15**
(c) 2PN
Wild type	13·65 ± 0·69	74·30 ± 0·73	9·79 ± 1·40	1·51 ± 0·24	1·02 ± 0·29
EphB2−/−	16·52 ± 1·37**	71·14 ± 3·25	10·09 ± 2·61	1·56 ± 0·38	2·81 ± 0·82**
EphB3−/−	16·55 ± 1·69*	72·99 ± 2·54	8·13 ± 0·65	1·49 ± 0·25	2·49 ± 0·27***
EphB2/B3−/−	17·17 ± 1·07***	71·91 ± 2·87	8·90 ± 1·03	1·58 ± 0·30	2·51 ± 0·10**

Showed data are means ± standard deviations.

^*P < 0.05

^**P < 0.01 and

^***P < 0.005.